Your browser doesn't support javascript.
loading
Treatment switch in Fabry disease- a matter of dose?
Lenders, Malte; Nordbeck, Peter; Canaan-Kühl, Sima; Kreul, Lukas; Duning, Thomas; Lorenz, Lora; Pogoda, Christian; Brand, Stefan-Martin; Wanner, Christoph; Brand, Eva.
Affiliation
  • Lenders M; Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany.
  • Nordbeck P; Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital and University of Würzburg, Würzburg, Germany.
  • Canaan-Kühl S; Department of Medicine, Division of Nephrology, Charité, Universitätsmedizin Campus Mitte, Berlin, Germany.
  • Kreul L; Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital and University of Würzburg, Würzburg, Germany.
  • Duning T; Department of Neurology, and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany.
  • Lorenz L; Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital and University of Würzburg, Würzburg, Germany.
  • Pogoda C; Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany.
  • Brand SM; Institute of Sports Medicine, Molecular Genetics of Cardiovascular Disease, and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany.
  • Wanner C; Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital and University of Würzburg, Würzburg, Germany.
  • Brand E; Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany Eva.Brand@ukmuenster.de.
J Med Genet ; 58(5): 342-350, 2021 05.
Article in En | MEDLINE | ID: mdl-32522756
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Alpha-Galactosidase / Isoenzymes Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: J Med Genet Year: 2021 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Alpha-Galactosidase / Isoenzymes Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: J Med Genet Year: 2021 Type: Article Affiliation country: Germany